- ESTE CONTENIDO SÓLO ESTÁ DISPONIBLE EN INGLÉS -
|
» The importance of Synovial Fluid
» Hyal-JointTM
» When is recommended?
» Components
» Clinical data
» Effects Synovial Fluid
» Recommended dosages
|
Click to visit Hyal-JointTM web site |
Clinical Data
|
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating
the Efficacy and Safety of Hyal-JointTM Compared with Placebo for the
Improvements of Quality of Life in Adults with Osteoarthritis of the Knee:
Average change from baseline in the SF-36v2 bodily-pain score for both groups during the trial.
Efficacy measures used in this study were WOMAC and the SF-36v2 Qualitity of Life.
Average change from baseline in the WOMAC ADL score for both groupsduring the trial
Results
Hyal-JointTM outperformed placebo in 5 of 6 SF-36v2 parameters including Bodily Pain, Role-Physical and Role-Emotional.
The group receiving Hyal-JointTM also experienced a significant improvement in the WOMAC-ADL.
There were notable differences between groups in the other efficacy variables.
Conclusion
Overall, the study indicates that Hyal-JointTM group showed improvement in most efficacy measures, and Hyal-JointTM
appeared to be beneficial for adults with OA of the knee.
That means the patient noticed a physical improvement and a reduction in the limitations suffered in activities of daily living
such as visiting friends, etc.
|
